These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 903075)

  • 1. Prolactinemia during hemodialysis: lack of correlation with sodium, potassium and renin-aldosterone system.
    Sciarra F; Sparano F; Giaquinto G; Odoardi A; Mercuri MA; Concolino G
    Horm Res; 1977; 8(3):129-38. PubMed ID: 903075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Nussberger J; Furrer J; Fontana A; Siegenthaler W
    Nephron; 1977; 18(2):114-23. PubMed ID: 857174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-dependent aldosterone secretion in anephric and nonnephrectomized patients on regular hemodialysis.
    Olgaard K; Madsen S; Hammer M; Ladefoged J
    J Clin Endocrinol Metab; 1978 May; 46(5):740-6. PubMed ID: 233632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of plasma aldosterone to sequential ultrafiltration, dialysis and conventional hemodialysis.
    Farinelli A; Squerzanti R; De Paoli Vitali E; Bagni B; Cavallini AR; Gilli P; Bedani PL
    Nephron; 1980; 26(6):274-9. PubMed ID: 7005702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine control of aldosterone secretion in end-stage renal failure.
    García-Robles R; Ruilope L; Tovar J; de Villa LF; Miranda B; Prieto C; Parada J; Sancho J; Rodicio JL
    Rev Esp Fisiol; 1986 Jun; 42(2):257-63. PubMed ID: 3092288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of prolactin inhibition by alpha-bromoergocriptine (CB 154) on plasma aldosterone in anephric and non-nephrectomized patients on regular haemodialysis.
    Olgaard K; Hagen C; Madsen S; Hummer L
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):587-94. PubMed ID: 194447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of plasma aldosterone in terminal renal failure before and after nephrectomy and after renal transplantation.
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Uhlschmid G; Furrer J; Siegenthaler W
    Clin Nephrol; 1976 Oct; 6(4):433-6. PubMed ID: 788978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of plasma renin, aldosterone, catecholamines and vasopressin in chronic ambulatory peritoneal dialysis (CAPD) patients.
    Zabetakis PM; Kumar DN; Gleim GW; Gardenswartz MH; Agrawal M; Robinson AG; Michelis MF
    Clin Nephrol; 1987 Sep; 28(3):147-51. PubMed ID: 3311503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of aldosterone secretion in anephric man.
    Bayard F; Cooke CR; Tiller DJ; Beitins IZ; Kowarski A; Walker WG; Migeon CJ
    J Clin Invest; 1971 Aug; 50(8):1585-95. PubMed ID: 4329001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The regulation of plasma aldosterone in hemodialysis patients].
    Louis F; Zwahlen A; Favre H; Vallotton M
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma aldosterone during extracellular fluid volume expansion in patients on regular haemodialysis.
    Olgaard K; Madsen S; Ladefoged J; Regeur L
    Eur J Clin Invest; 1977 Feb; 7(1):61-6. PubMed ID: 402278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of plasma aldosterone during chronic hemodialysis.
    Studer A; Záruba K; Grimm J; Kuhlmann U; Siegenthaler W; Vetter W
    Clin Nephrol; 1980 Apr; 13(4):172-6. PubMed ID: 6991183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone response to ACTH stimulation in anephric and non-nephrectomized patients on regular hemodialysis.
    Olgaard K; Madsen S
    Acta Med Scand; 1977 Jan; 201(1-2):77-82. PubMed ID: 189578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbuster H; Strebel U; Beckerhoff R; Siegenthaler W
    Proc Eur Dial Transplant Assoc; 1973; 10(0):332-41. PubMed ID: 4370265
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients.
    Van Stone JC; Bauer J; Carey J
    Am J Kidney Dis; 1982 Jul; 2(1):58-64. PubMed ID: 7048902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of aldosterone responsiveness in terminal renal failure.
    Weidmann P; Maxwell MH; De Lima J; Hirsch D; Franklin SS
    Kidney Int; 1975 May; 7(5):351-7. PubMed ID: 166231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL; Kutyrina IM
    Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of insulin-renin-aldosterone-potassium interrelationship in normal subjects, disrupted in chronic hemodialysis patients.
    Farfel Z; Iaina A; Eliahou HE
    J Clin Endocrinol Metab; 1978 Jul; 47(1):9-17. PubMed ID: 400716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A specific role for saline or the sodium ion in the regulation of renin and aldosterone secretion.
    Tuck ML; Dluhy RG; Williams GH
    J Clin Invest; 1974 Apr; 53(4):988-95. PubMed ID: 4360859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of plasma aldosterone in anephric and non-nephrectomized patients during hemodialysis treatment.
    Olgaard K; Madsen S
    Acta Med Scand; 1977; 201(5):457-62. PubMed ID: 899867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.